The facility will supply clinical trial materials for the development of vaccines and biologics up to Phase II stage and is expected to be fully operational by early 2023.
Strengthens supply chain continuity with first manufacturing facility outside of the U.S.
This expansion will support the global operations network and help meet global demand for mammalian development services that support Lonza’s manufacturing sites
Designed as an “AI-as-a-Service” platform, VECURA aims to reduce the traditional therapeutic drug discovery timeline of 10–12 years to just a few hours.
Kenox to provide formulation and development expertise in orally inhaled and nasal drug products
Adjusted EBITDA positive at Rs. 3.1 crore despite investments in marketing, talent hiring and technology over the year
The CDMO upgrade represents a transformational step for Remedium Lifecare
Celecoxib Capsules approval complements Strides’ existing products to serve a broader patient base
The system is powered by advanced imaging innovations such as Amber-red Color Imaging, Triple Noise Reduction, and Extended Dynamic Range Image Processing
Subscribe To Our Newsletter & Stay Updated
